Moderna
MRNA
#1332
Rank
$13.26 B
Marketcap
$34.30
Share price
-2.03%
Change (1 day)
-67.80%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total debt

Total debt on the balance sheet as of December 2024 : $0.74 Billion USD

According to Moderna 's latest financial reports the company's total debt is $0.74 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Moderna - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2024-12-31$0.74 B-39.9%
2023-12-31$1.24 B3.58%
2022-12-31$1.20 B31%
2021-12-31$0.91 B286.5%
2020-12-31$0.23 B79.05%
2019-12-31$0.13 B295.25%
2018-12-31$33.48 M113.48%
2017-12-31$15.68 M25.5%
2016-12-31$12.5 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
$0.47 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$37.11 B 4,868.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.57 M-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.29 B 73.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$31.25 B 4,084.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$0.52 B-29.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$36.63 B 4,804.15%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA